In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taking Stock Of Qiagen

Executive Summary

Since its acquisition of Digene in 2007, Qiagen's business mix has shifted significantly towards molecular diagnostics even as the company remains true to its founding premise of making things simpler for customers. It has broadened its skill set in nucleic acid analysis with multiple acquired and licensed technologies for platform development while focusing on high volume tests in women's health and infectious diseases and new ties with pharma. Expect its acquisition pattern to continue.
Advertisement

Related Content

Delivering Cancer Diagnostics Tools
What's Fueling The Recent Diagnostics Dealmaking?
Market & Industry Briefs
Nanostring Unveils Its Molecular Diagnostics Strategy
The How And When Of Applying Sequencing To Clinical Diagnostics
The How And When Of Applying Sequencing To Clinical Diagnostics
Leveraging Assay Platforms to Create Category-Killer Diagnostic Tests
Leveraging Assay Platforms to Create Category-Killer Diagnostic Tests
Digene's Long Road Towards a Blockbuster
Digene's Long Road Towards a Blockbuster

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003419

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel